Revenue $19.85B, up 3.6% on a year earlier. Diluted EPS $7.27 against $6.96.
| Q3 FY26 | Q2 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $19.85B | $20.23B | $19.16B | +3.6% |
| Operating income | $2.37B | $2.49B | $2.42B | -2.0% |
| Net income | $1.58B | $1.70B | $1.64B | -3.9% |
| Diluted EPS | $7.27 | $7.62 | $6.96 | |
| Operating cash flow | $4.46B | $2.33B | $4.42B | +1.0% |
| Capital expenditures | -$1.36B | -$1.23B | -$1.29B | |
| Free cash flow | $3.10B | $1.10B | $3.13B | -0.8% |
| Dividend per share | $0.78 | $0.78 | $0.72 |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “HCA Healthcare (HCA) Q3 FY26 earnings: results and KPIs”, stockatlas.com/companies/HCA/earnings/2026-q3/, data as of 3 November 2026. Links to this page are welcome.
